Author:
Elliott Jesse,Kelly Shannon E.,Bai Zemin,Skidmore Becky,Boucher Michel,So Derek,Wells George A.
Reference39 articles.
1. Optimal duration of dual antiplatelet therapy following percutaneous coronary intervention: an umbrella review;Elliott;Can J Cardiol,2019
2. Wells GA Elliott J Kelly S (2017) CADTH technology review, Dual antiplatelet therapy following percutaneous coronary intervention: a review of the clinical impact of treatment duration (Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa), 8.
3. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery
4. 2017 European Society of Cardiology (ESC) focused update on dual antiplatelet therapy in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);Jeppsson;Eur J Cardiothorac Surg,2018
5. 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy;Mehta;Can J Cardiol,2018
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献